Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
130.20
-1.64 (-1.24%)
At close: Jun 12, 2024, 4:00 PM
130.15
-0.05 (-0.04%)
Pre-market: Jun 13, 2024, 7:29 AM EDT

Merck & Co. Revenue

Merck & Co. had revenue of $61.40B in the twelve months ending March 31, 2024, with 6.11% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $15.78B with 8.89% year-over-year growth. In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth.

Revenue (ttm)
$61.40B
Revenue Growth
+6.11%
P/S Ratio
5.37
Revenue / Employee
$852,806
Employees
72,000
Market Cap
329.77B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B2.40B6.13%
Dec 31, 201939.12B-3.17B-7.50%
Dec 31, 201842.29B2.17B5.41%
Dec 31, 201740.12B315.00M0.79%
Dec 31, 201639.81B309.00M0.78%
Dec 31, 201539.50B-2.74B-6.48%
Dec 31, 201442.24B-1.80B-4.08%
Dec 31, 201344.03B-3.23B-6.84%
Dec 31, 201247.27B-780.00M-1.62%
Dec 31, 201148.05B2.06B4.48%
Dec 31, 201045.99B18.56B67.66%
Dec 31, 200927.43B3.58B15.00%
Dec 31, 200823.85B-347.70M-1.44%
Dec 31, 200724.20B1.56B6.90%
Dec 31, 200622.64B624.10M2.84%
Dec 31, 200522.01B-960.90M-4.18%
Dec 31, 200422.97B486.90M2.17%
Dec 31, 200322.49B1.04B4.85%
Dec 31, 200221.45B246.80M1.16%
Dec 31, 200121.20B-19.16B-47.48%
Dec 31, 200040.36B7.65B23.38%
Dec 31, 199932.71B5.82B21.62%
Dec 31, 199826.90B3.26B13.80%
Dec 31, 199723.64B3.81B19.21%
Dec 31, 199619.83B3.15B18.87%
Dec 31, 199516.68B1.71B11.43%
Dec 31, 199414.97B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Eli Lilly 35.93B
Revenue Rankings